Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews · Neonatal

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Summary of findings table ‐ Lignocaine vs benzodiazepines

Neurodevelopmental disability · neonates with EEG‐confirmed seizures

It is very uncertain whether summary of findings table ‐ Lignocaine changes neurodevelopmental disability at 12 months compared with benzodiazepines (very low certainty).

1 finding from 1 review

Anti‐seizure medications for neonates with seizures 2023 · Cochrane Headline outcomes only
RR 1 [0.36, 2.75]
1 study · 10 participants
Very low

Summary of findings table ‐ Lignocaine vs benzodiazepines

Mortality or neurodevelopmental disability at 12 months · neonates with EEG‐confirmed seizures

It is very uncertain whether summary of findings table ‐ Lignocaine changes mortality or neurodevelopmental disability at 12 months compared with benzodiazepines (very low certainty).

1 finding from 1 review

Anti‐seizure medications for neonates with seizures 2023 · Cochrane Headline outcomes only
RR 1 [0.71, 1.41]
1 study · 10 participants
Very low